The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Michael Karin

Laboratory of Gene Regulation and Signal Transduction

Department of Pharmacology

School of Medicine

University of California San Diego

USA

[email]@ucsd.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California San Diego, USA. 1998 - 2009

References

  1. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes. Karin, M., Gallagher, E. Immunol. Rev. (2009) [Pubmed]
  2. The IkappaB kinase - a bridge between inflammation and cancer. Karin, M. Cell Res. (2008) [Pubmed]
  3. Nuclear factor-kappaB in cancer development and progression. Karin, M. Nature (2006) [Pubmed]
  4. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Karin, M., Lawrence, T., Nizet, V. Cell (2006) [Pubmed]
  5. Role for IKK2 in muscle: waste not, want not. Karin, M. J. Clin. Invest. (2006) [Pubmed]
  6. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. Karin, M., Gallagher, E. IUBMB. Life (2005) [Pubmed]
  7. NF-kappaB: linking inflammation and immunity to cancer development and progression. Karin, M., Greten, F.R. Nat. Rev. Immunol. (2005) [Pubmed]
  8. Inflammation-activated protein kinases as targets for drug development. Karin, M. Proc. Am. Thorac. Soc (2005) [Pubmed]
  9. The IKK NF-kappa B system: a treasure trove for drug development. Karin, M., Yamamoto, Y., Wang, Q.M. Nat. Rev. Drug. Discov (2004) [Pubmed]
  10. Mitogen activated protein kinases as targets for development of novel anti-inflammatory drugs. Karin, M. Ann. Rheum. Dis. (2004) [Pubmed]
  11. NF-kappaB at the crossroads of life and death. Karin, M., Lin, A. Nat. Immunol. (2002) [Pubmed]
  12. NF-kappaB in cancer: from innocent bystander to major culprit. Karin, M., Cao, Y., Greten, F.R., Li, Z.W. Nat. Rev. Cancer (2002) [Pubmed]
  13. Is NF-kappaB2/p100 a direct activator of programmed cell death?. Häcker, H., Karin, M. Cancer. Cell (2002) [Pubmed]
  14. AP-1--glucocorticoid receptor crosstalk taken to a higher level. Karin, M., Chang, L. J. Endocrinol. (2001) [Pubmed]
  15. AP-1: linking hydrogen peroxide and oxidative stress to the control of cell proliferation and death. Karin, M., Shaulian, E. IUBMB. Life (2001) [Pubmed]
  16. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Karin, M., Ben-Neriah, Y. Annu. Rev. Immunol. (2000) [Pubmed]
  17. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. Karin, M. J. Biol. Chem. (1999) [Pubmed]
  18. JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?. Karin, M., Delhase, M. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
 
WikiGenes - Universities